U.S. researchers have shown that inhibiting c-Mer proto-oncogene tyrosine kinase, a protein that sits upstream from BRAF, reduced melanoma growth in mice. Future studies will need to determine whether inhibitors of this kinase are effective in BRAF-resistant tumors.